» Articles » PMID: 32155321

Mitochondrial and Mitochondrial-independent Pathways of Myocardial Cell Death During Ischaemia and Reperfusion Injury

Overview
Journal J Cell Mol Med
Date 2020 Mar 11
PMID 32155321
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Acute myocardial infarction causes lethal injury to cardiomyocytes during both ischaemia and reperfusion (IR). It is important to define the precise mechanisms by which they die in order to develop strategies to protect the heart from IR injury. Necrosis is known to play a major role in myocardial IR injury. There is also evidence for significant myocardial death by other pathways such as apoptosis, although this has been challenged. Mitochondria play a central role in both of these pathways of cell death, as either a causal mechanism is the case of mitochondrial permeability transition leading to necrosis, or as part of the signalling pathway in mitochondrial cytochrome c release and apoptosis. Autophagy may impact this process by removing dysfunctional proteins or even entire mitochondria through a process called mitophagy. More recently, roles for other programmed mechanisms of cell death such as necroptosis and pyroptosis have been described, and inhibitors of these pathways have been shown to be cardioprotective. In this review, we discuss both mitochondrial and mitochondrial-independent pathways of the major modes of cell death, their role in IR injury and their potential to be targeted as part of a cardioprotective strategy. This article is part of a special Issue entitled 'Mitochondria as targets of acute cardioprotection' and emerged as part of the discussions of the European Union (EU)-CARDIOPROTECTION Cooperation in Science and Technology (COST) Action, CA16225.

Citing Articles

Reperfused Myocardial Infarction: The Road to CCS Classification of Acute MI and Beyond.

Dharmakumar R, Kloner R, Fishbein M, Heusch G, Vora K, Gropler R JACC Adv. 2025; 4(2):101528.

PMID: 40021272 PMC: 11905164. DOI: 10.1016/j.jacadv.2024.101528.


Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.

Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E Antioxidants (Basel). 2025; 14(1).

PMID: 39857442 PMC: 11760872. DOI: 10.3390/antiox14010108.


Deciphering Oxidative Stress in Cardiovascular Disease Progression: A Blueprint for Mechanistic Understanding and Therapeutic Innovation.

Zhang Z, Guo J Antioxidants (Basel). 2025; 14(1).

PMID: 39857372 PMC: 11759168. DOI: 10.3390/antiox14010038.


Insight into interplay between PANoptosis and autophagy: novel therapeutics in ischemic stroke.

Tian H, Lei Y, Zhou J, Liu L, Yang T, Zhou Y Front Mol Neurosci. 2025; 17():1482015.

PMID: 39846000 PMC: 11751022. DOI: 10.3389/fnmol.2024.1482015.


Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect ischemia-reperfusion injury.

Li Y, Wang X, Meng X, Xia C, Yang C, Wang J Mol Med. 2024; 30(1):273.

PMID: 39719560 PMC: 11668014. DOI: 10.1186/s10020-024-01048-7.


References
1.
Nakahira K, Haspel J, Rathinam V, Lee S, Dolinay T, Lam H . Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2010; 12(3):222-30. PMC: 3079381. DOI: 10.1038/ni.1980. View

2.
Iyer S, He Q, Janczy J, Elliott E, Zhong Z, Olivier A . Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013; 39(2):311-323. PMC: 3779285. DOI: 10.1016/j.immuni.2013.08.001. View

3.
Shi H, Wang Y, Li X, Zhan X, Tang M, Fina M . NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2015; 17(3):250-8. PMC: 4862588. DOI: 10.1038/ni.3333. View

4.
Taabazuing C, Okondo M, Bachovchin D . Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. Cell Chem Biol. 2017; 24(4):507-514.e4. PMC: 5467448. DOI: 10.1016/j.chembiol.2017.03.009. View

5.
Tanzer M, Matti I, Hildebrand J, Young S, Wardak A, Tripaydonis A . Evolutionary divergence of the necroptosis effector MLKL. Cell Death Differ. 2016; 23(7):1185-97. PMC: 4946887. DOI: 10.1038/cdd.2015.169. View